Skip to main content
Commentary
Comparative effectiveness research in COVID-19 using real-world data: methodological considerations
- Stephanie H Read,
- Artak Khachatryan,
- Aastha Chandak,
- Roman Casciano,
- Paul Hodgkins,
- Richard Haubrich, and
- Essy Mozaffari
pp1259–1264
Published Online:31 August 2021
Letter to the Editor
Letter to the Editor: comparison of ofatumumab and other disease-modifying therapies for relapsing multiple sclerosis: a network meta-analysis
- Krupa Parekh and
- Claire Watkins
pp1265–1266
Published Online:5 October 2021
Letter in Reply
Letter in reply
- Imtiaz A Samjoo,
- Evelyn Worthington,
- Christopher Drudge,
- Melody Zhao,
- Chris Cameron,
- Dieter A Häring,
- Dee Stoneman,
- Luisa Klotz, and
- Nicholas Adlard
pp1267–1269
Published Online:5 October 2021
Research Article
Comparative effectiveness analysis between entrectinib clinical trial and crizotinib real-world data in ROS1+ NSCLC
- Robert C Doebele,
- Laura Perez,
- Huong Trinh,
- Michael Martinec,
- Reynaldo Martina,
- Todd Riehl,
- Matthew G Krebs,
- Neal J Meropol,
- William B Wong, and
- Gracy Crane
pp1271–1282
Published Online:24 August 2021
Budesonide/formoterol versus salmeterol/fluticasone for asthma in children: an effectiveness and safety analysis
- Ping Jiang,
- Lanyu Zhao, and
- Zezhong Yao
pp1283–1289
Published Online:20 October 2021
An observational cohort study of pelvic floor photobiomodulation for treatment of chronic pelvic pain
- Neeraj Kohli,
- Barry Jarnagin,
- Angela R Stoehr, and
- Georgine Lamvu
pp1291–1299
Published Online:7 September 2021
Meta-Analysis
Are treatment effects consistent with hypothesized mechanisms of action proposed for postoperative delirium interventions? Reanalysis of systematic reviews
- Emily G Boxell,
- Yuhaniz Malik,
- Jeyinn Wong,
- Min Hyung Lee,
- Hannah M Berntsson,
- Matthew J Lee,
- Richard S Bourne,
- Iain J McCullagh,
- Daniel Hind, and
- Matthew J Wilson
pp1301–1315
Published Online:29 September 2021